🧠 Health
Low-Dose Naltrexone (LDN) — Evidence, Uses, and How to Get It (2026)
Low-dose naltrexone is used off-label for chronic pain, autoimmune disease, and fatigue. What the evidence shows, how to access it, and who benefits most. Updated January 2026.
Key Takeaways
- LDN (1.5–4.5mg) is used at 1/10th the addiction medicine dose
- Growing evidence for fibromyalgia, MS, Crohn's disease, and ME/CFS
- Mechanism: brief opioid receptor blockade triggers endorphin upregulation and microglial modulation
- Generally well-tolerated — vivid dreams and sleep disruption most common side effects
- Only available via specialist prescription — not on NHS standard formulary
What Is Low-Dose Naltrexone?
Naltrexone is an opioid receptor antagonist approved at 50mg for alcohol and opioid dependence. Low-dose naltrexone (LDN) uses doses of 1.5–4.5mg — approximately one-tenth of the standard dose. At these low doses, it produces different biological effects, including modulation of the immune system and central nervous system inflammation.
1.5–4.5mg
LDN dose range (vs 50mg for addiction)
30–40%
Pain reduction reported in fibromyalgia trials
Off-label
Status in UK and USA — requires private prescription
How LDN Works
Two proposed mechanisms:
- Endorphin upregulation: Brief opioid receptor blockade (lasting 4–6 hours) triggers a compensatory increase in endorphin production — raising baseline endorphin levels and improving mood, pain tolerance, and immune function
- Microglial modulation: LDN blocks Toll-like receptor 4 (TLR4) on microglial cells (brain immune cells) — reducing neuroinflammation associated with chronic pain, fatigue, and autoimmune conditions
Evidence by Condition
| Condition | Evidence Level | Key Finding |
|---|---|---|
| Fibromyalgia | Moderate (RCTs) | 30–40% pain reduction; Stanford University trials |
| Multiple Sclerosis | Preliminary | Quality of life improvement; ongoing TREAT-MS trial |
| Crohn's Disease | Preliminary RCT | Remission in 33% vs 8% placebo (small trial) |
| ME/CFS | Case series + small RCT | Fatigue and pain reduction reported |
| Complex Regional Pain Syndrome | Case reports | Significant pain reduction in refractory cases |
| Long COVID | Emerging | Several ongoing trials; anecdotal reports promising |
Side Effects
- Vivid dreams / sleep disturbances: Most common — taking in morning (rather than bedtime) resolves this in most cases
- Transient flu-like symptoms: First few weeks of treatment
- Mild nausea: Usually resolves within 2 weeks
- No significant long-term side effects identified in available data
ℹ️ How to Access LDN
UK: LDN is not on NHS standard formulary but can be prescribed off-label by NHS or private doctors. The LDN Research Trust (ldnresearchtrust.org) maintains a list of UK prescribers. Cost: approximately £20–40/month from compounding pharmacies. USA: Prescribable off-label in all states; lowdosenaltrexone.org lists physicians. Always inform all treating doctors of any LDN use.Frequently Asked Questions
Is LDN safe long-term?▼
Available data (up to 10 years of case series) suggests LDN has an excellent long-term safety profile. No organ toxicity, no dependence, no tolerance development. The most important safety consideration: LDN blocks opioid receptors — cannot take opioid pain medications simultaneously. Complete opioid clearance is required before starting LDN.
Can I take LDN with other medications?▼
Critical interaction: cannot take with opioid medications (morphine, codeine, tramadol, oxycodone) — LDN blocks their effect completely. LDN may require dose adjustment of immunosuppressant medications in autoimmune conditions. Generally compatible with most non-opioid medications. Discuss full medication list with prescriber.
How long before LDN works?▼
Most people notice initial effects within 2–4 weeks. Full therapeutic effect typically develops over 2–3 months. Pain conditions may require longer — up to 6 months for maximum benefit. If no benefit by 3–4 months at 4.5mg, LDN is unlikely to be effective for that individual.
Related Health Guides
⚕️ Medical Disclaimer: For informational purposes only. Always consult a qualified healthcare professional before starting or changing any medication or treatment.
SM
Internal Medicine Physician
All articles reviewed by qualified healthcare professionals following NHS, AHA, and WHO guidelines.